Comments
Loading...

Cormedix

CRMDNASDAQ
Logo brought to you by Benzinga Data
$7.25
0.040.49%
At Close: -
$7.20
-0.04-0.62%
After Hours: 7:57 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$19.00
Lowest Price Target1
$9.00
Consensus Price Target1
$13.17

Cormedix (NASDAQ:CRMD) Stock, Analyst Ratings, Price Targets, Forecasts

Cormedix Inc has a consensus price target of $13.17 based on the ratings of 6 analysts. The high is $19 issued by JMP Securities on April 9, 2024. The low is $9 issued by RBC Capital on August 15, 2024. The 3 most-recent analyst ratings were released by Rodman & Renshaw, RBC Capital, and Needham on August 26, 2024, August 15, 2024, and August 15, 2024, respectively. With an average price target of $10.67 between Rodman & Renshaw, RBC Capital, and Needham, there's an implied 48.15% upside for Cormedix Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Jun
0
0
0
0
Jul
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Rodman & Renshaw
RBC Capital
Needham
Truist Securities
JMP Securities

1calculated from analyst ratings

Analyst Ratings for Cormedix

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Cormedix (CRMD) stock?

A

The latest price target for Cormedix (NASDAQ:CRMD) was reported by Rodman & Renshaw on August 26, 2024. The analyst firm set a price target for $13.00 expecting CRMD to rise to within 12 months (a possible 80.56% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cormedix (CRMD)?

A

The latest analyst rating for Cormedix (NASDAQ:CRMD) was provided by Rodman & Renshaw, and Cormedix initiated their buy rating.

Q

When was the last upgrade for Cormedix (CRMD)?

A

There is no last upgrade for Cormedix

Q

When was the last downgrade for Cormedix (CRMD)?

A

There is no last downgrade for Cormedix.

Q

When is the next analyst rating going to be posted or updated for Cormedix (CRMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cormedix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cormedix was filed on August 26, 2024 so you should expect the next rating to be made available sometime around August 26, 2025.

Q

Is the Analyst Rating Cormedix (CRMD) correct?

A

While ratings are subjective and will change, the latest Cormedix (CRMD) rating was a initiated with a price target of $0.00 to $13.00. The current price Cormedix (CRMD) is trading at is $7.20, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch